MicroRNAs: where brilliance, perseverance, and ambition converged

Victor Ambros at the University of Massachusetts Medical School and Gary Ruvkun at Harvard University were awarded the 2024 Nobel Prize in Medicine and Physiology for the discovery of microRNAs. This “groundbreaking discovery revealed a completely new principle of gene regulation that turned out to be essential for multicellular organisms, including humans” (1). This is a well-deserved and highly anticipated recognition for a seminal discovery published 31 years ago in back-to-back Cell publications (2, 3). This landmark finding changed the way we understand gene expression regulation among most multicellular organisms (4) and had a huge impact in deciphering the mechanisms of many diseases.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Investigation
Published
2024-12-10
DOI
https://doi.org/10.1172/jci189625
Citations
3
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MicroRNAs: where brilliance, perseverance, and ambition converged

George A. Călin, Rareş Drulă
3 citations
Journal of Clinical Investigation
MicroRNA in disease regulation
0.86
article

MicroRNAs: where brilliance, perseverance, and ambition converged

George A. Călin, Rareş Drulă
article en
3 citations

Abstract

Victor Ambros at the University of Massachusetts Medical School and Gary Ruvkun at Harvard University were awarded the 2024 Nobel Prize in Medicine and Physiology for the discovery of microRNAs. This “groundbreaking discovery revealed a completely new principle of gene regulation that turned out to be essential for multicellular organisms, including humans” (1). This is a well-deserved and highly anticipated recognition for a seminal discovery published 31 years ago in back-to-back Cell publications (2, 3). This landmark finding changed the way we understand gene expression regulation among most multicellular organisms (4) and had a huge impact in deciphering the mechanisms of many diseases.

Journal of Clinical InvestigationVol. 135(2)
The University of Texas MD Anderson Cancer Center (US), Leukemia Research Foundation (US), Center for Translational Molecular Medicine (NL)
U.S. Department of Defense, CLL Global Research Foundation, University of Texas MD Anderson Cancer Center, National Cancer Institute, National Institute of Dental and Craniofacial Research
Reduced inequalities
Openalex Percentile: Top 24%
MicroRNA in disease regulation
0.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.